A Marfan-szindroma cardiovascularis vonatkozasai

Translated title of the contribution: Cardiovascular manifestations in Marfan's syndrome

Research output: Contribution to journalArticle

Abstract

Marfan's syndrome is an autosomal dominant disorder in which life expectancy is markedly shortened. Mortality is due to cardiovascular abnormalities in 80% of cases, mostly to aortic root dilatation and its complications, aortic dissection and rupture. The diagnostic technique of choice is echocardiography, for suspected dissection transesophageal echocardiography. Aortic dilatation measured by echocardiography increases progressively with age. Conservative treatment includes echocardiographic screening, monitoring and the beta-blocker treatment started at an early age. Pregnancy and labour are serious risk factors for dissection even without aortic root dilatation, therefore special, counselling, monitoring and management are indicated. Life expectancy has been significantly increased with surgical treatment. Besides emergency and elective surgical indications prophylactic indications have been advocated. Aortic root dilatation and its complications are surgically treated by composite graft repair. Prophylactic surgery is indicated if the aortic root is dilated without aortic regurgitation or dissection. Operative mortality in Marfan's syndrome is less than 10%, the 5 year survival is over 90%, but late complications and the need of reoperations are frequent. Prophylactic operation has got no mortality and the necessity of reoperations is infrequent. Recent guidelines for the management of the Marfan patients recommend echocardiographic screening and early initiation of beta-blockade, annual echo monitoring and surgical referral at 50 mm of aortic root dimension in the presence of symptoms or additional factors (positive family history, severe mitral regurgitation, moderately-to-severe aortic regurgitation, planned pregnancy) and at 55 mm of aortic root dimension even without symptoms and the above additional factors.

Original languageHungarian
Pages (from-to)108-114
Number of pages7
JournalLege Artis Medicinae
Volume7
Issue number3
Publication statusPublished - 1997

Fingerprint

Marfan Syndrome
Dissection
Dilatation
Aortic Valve Insufficiency
Life Expectancy
Reoperation
Echocardiography
Mortality
Cardiovascular Abnormalities
Aortic Rupture
Transesophageal Echocardiography
Family Planning Services
Mitral Valve Insufficiency
Counseling
Emergencies
Referral and Consultation
Guidelines
Transplants
Pregnancy
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A Marfan-szindroma cardiovascularis vonatkozasai. / Lengyel, M.

In: Lege Artis Medicinae, Vol. 7, No. 3, 1997, p. 108-114.

Research output: Contribution to journalArticle

@article{90e4f3c986c946aaaa583622f1a27f3f,
title = "A Marfan-szindroma cardiovascularis vonatkozasai",
abstract = "Marfan's syndrome is an autosomal dominant disorder in which life expectancy is markedly shortened. Mortality is due to cardiovascular abnormalities in 80{\%} of cases, mostly to aortic root dilatation and its complications, aortic dissection and rupture. The diagnostic technique of choice is echocardiography, for suspected dissection transesophageal echocardiography. Aortic dilatation measured by echocardiography increases progressively with age. Conservative treatment includes echocardiographic screening, monitoring and the beta-blocker treatment started at an early age. Pregnancy and labour are serious risk factors for dissection even without aortic root dilatation, therefore special, counselling, monitoring and management are indicated. Life expectancy has been significantly increased with surgical treatment. Besides emergency and elective surgical indications prophylactic indications have been advocated. Aortic root dilatation and its complications are surgically treated by composite graft repair. Prophylactic surgery is indicated if the aortic root is dilated without aortic regurgitation or dissection. Operative mortality in Marfan's syndrome is less than 10{\%}, the 5 year survival is over 90{\%}, but late complications and the need of reoperations are frequent. Prophylactic operation has got no mortality and the necessity of reoperations is infrequent. Recent guidelines for the management of the Marfan patients recommend echocardiographic screening and early initiation of beta-blockade, annual echo monitoring and surgical referral at 50 mm of aortic root dimension in the presence of symptoms or additional factors (positive family history, severe mitral regurgitation, moderately-to-severe aortic regurgitation, planned pregnancy) and at 55 mm of aortic root dimension even without symptoms and the above additional factors.",
keywords = "Aortic dissection, Aortic root dilatation, Beta-receptor blocker treatment, Echocardiography, Marfan's syndrome, Prophylactic operation",
author = "M. Lengyel",
year = "1997",
language = "Hungarian",
volume = "7",
pages = "108--114",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "3",

}

TY - JOUR

T1 - A Marfan-szindroma cardiovascularis vonatkozasai

AU - Lengyel, M.

PY - 1997

Y1 - 1997

N2 - Marfan's syndrome is an autosomal dominant disorder in which life expectancy is markedly shortened. Mortality is due to cardiovascular abnormalities in 80% of cases, mostly to aortic root dilatation and its complications, aortic dissection and rupture. The diagnostic technique of choice is echocardiography, for suspected dissection transesophageal echocardiography. Aortic dilatation measured by echocardiography increases progressively with age. Conservative treatment includes echocardiographic screening, monitoring and the beta-blocker treatment started at an early age. Pregnancy and labour are serious risk factors for dissection even without aortic root dilatation, therefore special, counselling, monitoring and management are indicated. Life expectancy has been significantly increased with surgical treatment. Besides emergency and elective surgical indications prophylactic indications have been advocated. Aortic root dilatation and its complications are surgically treated by composite graft repair. Prophylactic surgery is indicated if the aortic root is dilated without aortic regurgitation or dissection. Operative mortality in Marfan's syndrome is less than 10%, the 5 year survival is over 90%, but late complications and the need of reoperations are frequent. Prophylactic operation has got no mortality and the necessity of reoperations is infrequent. Recent guidelines for the management of the Marfan patients recommend echocardiographic screening and early initiation of beta-blockade, annual echo monitoring and surgical referral at 50 mm of aortic root dimension in the presence of symptoms or additional factors (positive family history, severe mitral regurgitation, moderately-to-severe aortic regurgitation, planned pregnancy) and at 55 mm of aortic root dimension even without symptoms and the above additional factors.

AB - Marfan's syndrome is an autosomal dominant disorder in which life expectancy is markedly shortened. Mortality is due to cardiovascular abnormalities in 80% of cases, mostly to aortic root dilatation and its complications, aortic dissection and rupture. The diagnostic technique of choice is echocardiography, for suspected dissection transesophageal echocardiography. Aortic dilatation measured by echocardiography increases progressively with age. Conservative treatment includes echocardiographic screening, monitoring and the beta-blocker treatment started at an early age. Pregnancy and labour are serious risk factors for dissection even without aortic root dilatation, therefore special, counselling, monitoring and management are indicated. Life expectancy has been significantly increased with surgical treatment. Besides emergency and elective surgical indications prophylactic indications have been advocated. Aortic root dilatation and its complications are surgically treated by composite graft repair. Prophylactic surgery is indicated if the aortic root is dilated without aortic regurgitation or dissection. Operative mortality in Marfan's syndrome is less than 10%, the 5 year survival is over 90%, but late complications and the need of reoperations are frequent. Prophylactic operation has got no mortality and the necessity of reoperations is infrequent. Recent guidelines for the management of the Marfan patients recommend echocardiographic screening and early initiation of beta-blockade, annual echo monitoring and surgical referral at 50 mm of aortic root dimension in the presence of symptoms or additional factors (positive family history, severe mitral regurgitation, moderately-to-severe aortic regurgitation, planned pregnancy) and at 55 mm of aortic root dimension even without symptoms and the above additional factors.

KW - Aortic dissection

KW - Aortic root dilatation

KW - Beta-receptor blocker treatment

KW - Echocardiography

KW - Marfan's syndrome

KW - Prophylactic operation

UR - http://www.scopus.com/inward/record.url?scp=0030952611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030952611&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 108

EP - 114

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 3

ER -